4.8 News Item

Gene-silencing drug approved

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

D. Adams et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)